|
ISIN No
|
INE03QK01018
|
BSE Code / NSE Code
|
543064 / COHANCE
|
Book Value (Rs.)
|
99.01
|
Face Value
|
1.00
|
|
Bookclosure
|
09/08/2024
|
52Week High
|
1328
|
EPS
|
7.00
|
P/E
|
74.02
|
|
Market Cap.
|
19828.45 Cr.
|
52Week Low
|
515
|
P/BV / Div Yield (%)
|
5.23 / 0.00
|
Market Lot
|
1.00
|
|
Security Type
|
Other
|
|
The company history sections lists out major chronological events that happened to the company.
The Company was incorporated as a public limited company under the Companies Act, 2013, in Hyderabad, Telangana, India, pursuant to a certificate of incorporation dated November 6, 2018 issued by the Registrar of Companies, Telangana, at Hyderabad.
2020
-Suven Pharmaceuticals Ltd. has issued Bonus Shares in the Ratio of 1:1.
2021
-CSIR-IICT and SUVEN Pharmaceuticals Ltd., joined hands for the process technology
transfer and manufacture of anti COVID drugs Molnupiravir and 2-DG.
2022
-Advent to acquire significant stake in Suven Pharmaceuticals from Jasti family.
-Suven Pharmaceuticals approves acquisition of Casper Pharma.
|